The severity of mitral regurgitation is decided by all of the following clinical findings except –
**Core Concept**
Mitral regurgitation (MR) is a condition where the mitral valve fails to close properly, allowing blood to flow backward from the left ventricle into the left atrium during systole. The severity of MR is determined by the amount of blood regurgitated, which can be assessed through various clinical findings.
**Why the Correct Answer is Right**
The severity of MR is decided by the clinical findings of the regurgitant volume and the left ventricular function. The regurgitant volume is the amount of blood that leaks back into the left atrium during systole, and it can be estimated through echocardiography. The left ventricular function is also an important factor, as a dilated left ventricle with poor contractility can tolerate more regurgitant volume without symptoms. However, the correct answer will be the option that does not contribute to the assessment of MR severity.
**Why Each Wrong Option is Incorrect**
* **Option A:** Left atrial enlargement is a consequence of chronic MR, but it is not a direct measure of the severity of the regurgitation. **Left atrial enlargement can occur at any stage of MR severity.**
* **Option B:** Pulmonary hypertension, a complication of chronic MR, can be associated with severe MR, but it is not a direct measure of the severity of the regurgitation. **Pulmonary hypertension can develop at any stage of MR severity.**
* **Option C:** The presence of symptoms, such as dyspnea and fatigue, is a clinical indicator of severe MR. **Symptoms are a direct result of the regurgitant volume and left ventricular function.**
**Clinical Pearl / High-Yield Fact**
The severity of MR can be estimated using the regurgitant fraction, which is the ratio of the regurgitant volume to the left ventricular stroke volume. A regurgitant fraction of 0.5 or greater is considered severe MR.
**Correct Answer: C. The presence of symptoms, such as dyspnea and fatigue, is a clinical indicator of severe MR.**